DrugPatentWatch Database Preview
NOVOLOG MIX 70/30 Drug Profile
Email this page to a colleague
» See Plans and PricingSummary for Tradename: NOVOLOG MIX 70/30
| Patents: | 0 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for NOVOLOG MIX 70/30 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for NOVOLOG MIX 70/30 |
Recent Clinical Trials for NOVOLOG MIX 70/30
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Gan and Lee Pharmaceuticals, USA | Phase 1 |
| Texas Diabetes & Endocrinology, P.A. | Phase 3 |
| Mylan Inc. | Phase 3 |
Recent Litigation for NOVOLOG MIX 70/30
Identify key patents and potential future biosimilar entrants
District Court Litigation
| Case Name | Date |
|---|---|
| SANOFI-AVENTIS U.S. LLC v. MYLAN N v. | 2017-10-24 |
| Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc. | 2017-03-03 |
| SMITH v. NOVO NORDISK INC. | 2016-08-08 |
